Authors:
Gulwadi, AG
Korpinen, CD
Mailman, RB
Nichols, DE
Sit, SY
Taber, MT
Citation: Ag. Gulwadi et al., Dinapsoline: Characterization of a D-1 dopamine receptor agonist in a rat model of Parkinson's disease, J PHARM EXP, 296(2), 2001, pp. 338-344
Authors:
Miyamoto, S
Mailman, RB
Lieberman, JA
Duncan, GE
Citation: S. Miyamoto et al., Blunted brain metabolic response to ketamine in mice lacking D-1A dopaminereceptors, BRAIN RES, 894(2), 2001, pp. 167-180
Authors:
Lawler, CP
Prioleau, C
Lewis, MM
Mak, C
Jiang, D
Schetz, JA
Gonzalez, AM
Sibley, DR
Mailman, RB
Citation: Cp. Lawler et al., Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes, NEUROPSYCH, 20(6), 1999, pp. 612-627
Authors:
Doll, MKH
Nichols, DE
Kilts, JD
Prioleau, C
Lawler, CP
Lewis, MM
Mailman, RB
Citation: Mkh. Doll et al., Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane, J MED CHEM, 42(5), 1999, pp. 935-940
Authors:
Hoffman, B
Cho, SJ
Zheng, WF
Wyrick, S
Nichols, DE
Mailman, RB
Tropsha, A
Citation: B. Hoffman et al., Quantitative structure-activity relationship modeling of dopamine D-1 antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods, J MED CHEM, 42(17), 1999, pp. 3217-3226